← Back to Search

Managed Problem Solving for HIV/AIDS Care

Q: Are there any vacancies available for individuals to participate in this trial?

<p>The evidence on clinicaltrials.gov unambiguously suggests that this medical study is actively enrolling patients. This trial was initially posted in February of 2022 and a recent update was made to the page on May 13th 2022.</p>

Q: What is the current capacity of participants for this trial?

<p>Yes, the information on clinicialtrials.gov denotes that this clinical trial is currently recruiting patients. This medical experiment was initially posted on February 1st 2022 and has since been updated to its current form as of May 13th 2022. The study requires 780 participants from 4 distinct sites.</p>

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

age 18 or older

A man or woman living with HIV

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one year

Awards & highlights

Study Summary

This trial is testing a behavior change intervention delivered by community health workers to improve viral suppression and care retention in people living with HIV.

Who is the study for?

This trial is for adults living with HIV who are not consistently in care or have not achieved viral suppression. It's specifically designed to help those who may benefit from additional support by Community Health Workers.Check my eligibility

What is being tested?

The trial tests a behavioral intervention called Managed Problem Solving (MAPS+), delivered by Community Health Workers, aimed at improving medication adherence and retention in HIV care. The effectiveness of MAPS+ will be compared to usual care across several clinics.See study design

What are the potential side effects?

Since MAPS+ is a behavioral intervention rather than a medical treatment, it does not have traditional side effects like drugs do. However, participants might experience stress or discomfort discussing personal issues during the problem-solving sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am living with HIV.

Select...

I am 18 years old or older.

Select...

I am living with HIV.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Undetectable HIV viral load (<20 copies/ml)

Secondary outcome measures

Adherence to HIV therapy

CD4 Count

Retention in care

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MAPS+Experimental Treatment1 Intervention

Group II: Standard of CareActive Control1 Intervention

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,012 Previous Clinical Trials

42,891,752 Total Patients Enrolled

Media Library

Managed Problem Solving (MAPS) Clinical Trial Eligibility Overview. Trial Name: NCT04560621 — N/A

HIV/AIDS Research Study Groups: MAPS+, Standard of Care

HIV/AIDS Clinical Trial 2023: Managed Problem Solving (MAPS) Highlights & Side Effects. Trial Name: NCT04560621 — N/A

Managed Problem Solving (MAPS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04560621 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for individuals to participate in this trial?

"The evidence on clinicaltrials.gov unambiguously suggests that this medical study is actively enrolling patients. This trial was initially posted in February of 2022 and a recent update was made to the page on May 13th 2022."

Answered by AI

What is the current capacity of participants for this trial?

"Yes, the information on clinicialtrials.gov denotes that this clinical trial is currently recruiting patients. This medical experiment was initially posted on February 1st 2022 and has since been updated to its current form as of May 13th 2022. The study requires 780 participants from 4 distinct sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers

Florence Momplaisir, MD 2022. "Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04560621.

All > Aids